Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
Open Access
- 15 January 2022
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 17 (1) , 1-10
Abstract
Background: Loss of brain capillary pericyte is involved in the pathologies and cognitive deficits in Alzheimer’s disease (AD). The role of pericyte in early stage of AD pathogenesis remains unclear. Methods: We investigated the dynamic changes of soluble platelet-derived growth factor receptor β (sPDGFRβ) in cerebrospinal fluid (CSF), a marker of brain pericyte injury, in transition from normal ageing to early AD in a cognitively unimpaired population aged 20 to 90 years. Association between sPDGFRβ and ATN biomarkers were analyzed. Results: In lifetime, CSF sPDGFRβ continually increased since age of 20 years, followed by the increases of phosphorylated tau-181 (P-tau181) and total tau (T-tau) at the age of 22.2 years and 31.7 years, respectively; CSF Aβ42 began to decline since the age of 39.6 years, indicating Aβ deposition. The natural trajectories of biomarkers suggest that pericyte injury is an early event during transition from normal status to AD, even earlier than Aβ deposition. In AD spectrum, CSF sPDGFRβ was elevated in preclinical stage 2 and participants with suspected non-AD pathophysiologies. Additionally, CSF sPDGFRβ was positively associated with P-tau181 and T-tau independently of Aβ42, and significantly strengthened the effects of Aβ42 on P-tau181, suggesting that pericyte injury accelerates Aβ-mediated tau hyperphosphorylation. Conclusions: Our results suggest that pericyte injury contributes to AD progression in the early stage in an Aβ-independent pathway. Recovery of pericyte function would be a target for prevention and early intervention of AD.Keywords
Funding Information
- National Natural Science Foundation of China (82171418, 82120108010)
This publication has 33 references indexed in Scilit:
- Amyloid‐β efflux from the central nervous system into the plasmaAnnals of Neurology, 2014
- A role for human brain pericytes in neuroinflammationJournal of Neuroinflammation, 2014
- RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in miceNature Communications, 2013
- Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating CentreBrain, 2013
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years laterNeurology, 2013
- Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's DiseaseBrain Pathology, 2012
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 2011
- Visinin‐like protein‐1: Diagnostic and prognostic biomarker in Alzheimer diseaseAnnals of Neurology, 2011
- Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain AgingNeuron, 2010
- Pericytes regulate the blood–brain barrierNature, 2010